NAGE•benzinga•
Roth Capital Maintains Buy on Niagen Bioscience, Raises Price Target to $23
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 6, 2025 by benzinga